Drug Survival of Upadacitinib and Predicting Factors of Discontinuation in Adult Patients Affected by Moderate-to-Severe Atopic Dermatitis: An Italian Multicenter Analysis.
Pezzolo E, Ortoncelli M, Ferrucci SM, Guanti MB, Schena D, Napolitano M, Rossi M, Foti C, D'Amico D, Amoruso GF, Morrone P, Ribero S, Barei F, Biagi M, Pascucci E, Patruno C, Calzavara Pinton P, Romita P, Gargiulo L, Narcisi A, Naldi L.
Pezzolo E, et al. Among authors: narcisi a.
J Clin Med. 2024 Jan 18;13(2):553. doi: 10.3390/jcm13020553.
J Clin Med. 2024.
PMID: 38256686
Free PMC article.